Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Payables (2012 - 2026)

Kamada's (KMDA) quarterly Payables came in at $28.4 million in Q2 2026, up 13.06% on a YoY basis from $25.1 million in Q2 2025, and up 29.23% quarter-over-quarter from $21.9 million in Q1 2026.

Analysis

Kamada (KMDA) Payables (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Payables for 15 consecutive years, with $28.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Payables rose 13.06% year-over-year to $28.4 million; the trailing twelve-month figure through Jun 2026 stood at $28.4 million (up 13.06% YoY), and the FY2025 full-year result was $23.2 million, down 16.79% from the prior year.
  • Payables improved to $28.4 million in Q2 2026 per KMDA's latest filing, from $21.9 million in the prior quarter.
  • Across five years, Payables topped out at $37.4 million in Q4 2022 and bottomed at $11.7 million in Q1 2022.
  • Historically, Payables has averaged $23.4 million across 5 years, with a median of $24.9 million in 2025.
  • The widest YoY moves for Payables: up 124.4% in 2023, down 58.16% in 2023.
  • Over 5 years, Payables stood at $37.4 million in 2022, then plunged by 33.21% to $25.0 million in 2023, then advanced by 11.94% to $27.9 million in 2024, then decreased by 16.79% to $23.2 million in 2025, then climbed by 21.98% to $28.4 million in 2026.
  • According to Business Quant data, Payables over the past three periods registered $28.4 million, $21.9 million, and $23.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.52 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 25.08 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn 28.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.35 Mn
Mar 31, 2026 21.94 Mn
Dec 31, 2025 23.24 Mn
Sep 30, 2025 24.88 Mn
Jun 30, 2025 25.08 Mn
Mar 31, 2025 24.85 Mn
Dec 31, 2024 27.93 Mn
Sep 30, 2024 14.79 Mn
Jun 30, 2024 19.53 Mn
Mar 31, 2024 16.49 Mn
Dec 31, 2023 24.95 Mn
Sep 30, 2023 12.81 Mn
Jun 30, 2023 32.41 Mn
Mar 31, 2023 26.21 Mn
Dec 31, 2022 37.36 Mn
Sep 30, 2022 30.62 Mn
Jun 30, 2022 17.95 Mn
Mar 31, 2022 11.68 Mn
Dec 31, 2021 25.10 Mn
Sep 30, 2021 19.01 Mn